Pathstone Holdings’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.38M Buy
34,253
+337
+1% +$22.2K 0.01% 1014
2026
Q1
$2.34M Sell
33,916
-3,150
-8% -$246K 0.01% 951
2025
Q4
$3.27M Buy
37,066
+892
+2% +$75.9K 0.01% 766
2025
Q3
$3.01M Sell
36,174
-5,281
-13% -$460K 0.01% 805
2025
Q2
$3.88M Buy
41,455
+1,352
+3% +$128K 0.02% 644
2025
Q1
$4.24M Buy
40,103
+3,675
+10% +$379K 0.02% 613
2024
Q4
$3.52M Buy
36,428
+1,478
+4% +$147K 0.02% 685
2024
Q3
$3.45M Buy
34,950
+5,844
+20% +$535K 0.02% 697
2024
Q2
$2.5M Buy
29,106
+2,660
+10% +$209K 0.01% 822
2024
Q1
$2M Buy
26,446
+12,628
+91% +$975K 0.01% 901
2023
Q4
$1.05M Buy
+13,818
New +$965K 0.01% 1056

Other funds holding MMSI

Pathstone Holdings's MMSI Position: Q2 2026 in Review

Pathstone Holdings increased its Merit Medical Systems (MMSI) stake by 0.99% in Q2 2026, buying an estimated $22.2K and bringing the position to 34,253 shares worth $2.38M. The position accounts for 0.01% of the portfolio, ranked #1014.

Pathstone Holdings first reported a position in MMSI in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.24M in Q1 2025. 403 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Pathstone Holdings held 34,253 shares of Merit Medical Systems worth $2.38M as of Q2 2026.
  • Pathstone Holdings bought 337 Merit Medical Systems shares in Q2 2026, an estimated $22.2K.
  • Merit Medical Systems made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1014 holding.
  • Pathstone Holdings first reported a position in Merit Medical Systems in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Merit Medical Systems position peaked at $4.24M in Q1 2025.
  • 403 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.